Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
€6.00
31.07.27
-44.67%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-24.14%
04.03.24

Risky Investment
robertinio 
19.02.24 0%
sell
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
robertinio 
19.02.24 0%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.01
18.02.24
-
18.02.25
-2.59%
03.03.24

Risky Investment
blaugold 
18.02.24 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1.65
18.02.24
-
18.02.25
11.85%
02.05.24

StockNews.com 
18.02.24 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.51
18.02.24
-
18.02.25
-63.22%
12.08.24

StockNews.com 
18.02.24 50%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
18.02.24
€4.00
31.01.26
-0.09%
12:23

Could be very worthwhile Investment >20% year
BiotechBee 
18.02.24 60%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
17.02.24
€11.00
31.01.26
-33.40%
11:03

Could be very worthwhile Investment >20% year
BiotechBee 
17.02.24 80%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.30
17.02.24
€76.07
17.02.25
-6.20%
09:30

Mizuho 
17.02.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.60
17.02.24
€36.18
17.02.25
-70.45%
30.08.24

Mizuho 
17.02.24 50%
sell
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
17.02.24
-
17.02.25
-48.65%
30.08.24

StockNews.com 
17.02.24 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.00
17.02.24
-
17.02.25
53.10%
09:30

StockNews.com 
17.02.24 50%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€0.37
17.02.24
-
17.02.25
-
05.12.22

StockNews.com 
17.02.24 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.69
17.02.24
-
17.02.25
66.08%
29.08.24

StockNews.com 
17.02.24 50%
sell
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€41.07
17.02.24
-
17.02.25
4.33%
10:47

StockNews.com 
17.02.24 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
17.02.24
-
17.02.25
-
07.01.23

StockNews.com 
17.02.24 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.47
17.02.24
-
17.02.25
-12.39%
21.03.24

StockNews.com 
17.02.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€13.70
17.02.24
€14.00
17.02.25
2.15%
23.02.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
17.02.24 50%
buy
XOMA Corp.

Start price
Target price
Perf. (%)
€21.80
16.02.24
€68.62
16.02.25
23.40%
30.08.24

HC Wainwright 
16.02.24 50%
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.53
16.02.24
€11.13
16.02.25
-77.87%
12:10

UBS Group AG 
16.02.24 50%
buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€316.20
16.02.24
€389.51
16.02.25
-3.45%
30.08.24

UBS Group AG 
16.02.24 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
16.02.24
€53.79
16.02.25
-
30.09.21

UBS Group AG 
16.02.24 50%
buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€316.20
16.02.24
€445.58
16.02.25
-3.45%
30.08.24

Royal Bank of Canada 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€136.40
16.02.24
€210.72
16.02.25
74.71%
09:30

Citigroup Inc. 
16.02.24 50%